Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bio-TechneMEX:TECH 88 EV-to-EBITDA is 30.53 as of Aug. 19, 2026, which is 6% below its 10-year median of 32.46. GuruFocus rates MEX:TECH with a GF Score™ of 88/100 and a GF Value™ of MXN1,071.89. The stock has 7 warning signs investors should review. Among 401 Biotechnology companies, Bio-Techne ranks worse than 74.06% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bio-Techne's enterprise value is MXN192,113 Mil.
Bio-Techne's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was MXN6,294 Mil. Therefore, Bio-Techne's EV-to-EBITDA for today is 30.53.
The historical rank and industry rank for Bio-Techne's EV-to-EBITDA or its related term are showing as below:
MEX:TECH'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 20.02 Med: 32.46 Max: 89.25
Current: 32.13
During the past 13 years, the highest EV-to-EBITDA of Bio-Techne was 89.25. The lowest was 20.02. And the median was 32.46.
MEX:TECH's EV-to-EBITDA is ranked worse than 74.06% of 401
companies
in the Biotechnology industry
Industry Median: 13.6
vs MEX:TECH: 32.13
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bio-Techne's share price for today is MXN1090.00.
Bio-Techne's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN20.541.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Bio-Techne's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TECH vs CYTK, SMMT, BMRN: EV-to-EBITDA Comparison
For the Biotechnology subindustry, Bio-Techne's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne EV-to-EBITDA vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Techne's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bio-Techne's EV-to-EBITDA falls into.
Bio-Techne's current Enterprise Value is MXN192,113 Mil.
Bio-Techne's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN6,294 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne (MEX:TECH) has a EV-to-EBITDA of 30.53 as of Aug. 19, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bio-Techne. This is near median its historical median of 32.46. Over the past decade, Bio-Techne's EV-to-EBITDA has ranged from 20.02 to 89.25. According to the industry distribution chart, Bio-Techne ranks #297 out of 401 companies in the Biotechnology industry, placing it in the top 74.1%.
Is Bio-Techne's EV-to-EBITDA too high?
Bio-Techne's current EV-to-EBITDA of 30.53 is near median its 10-year median of 32.46. Over the past 10 years, this metric has ranged from a low of 20.02 to a high of 89.25. The Biotechnology industry median EV-to-EBITDA is 13.60. Bio-Techne's value of 30.53 is 124.5% above this industry median. Based on the distribution chart, Bio-Techne ranks #297 out of 401 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Bio-Techne has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's EV-to-EBITDA compare to CYTK and SMMT?
According to the Biotechnology industry distribution chart, Bio-Techne ranks #297 out of 401 companies for EV-to-EBITDA. This places Bio-Techne in the lower half of its industry. The industry median EV-to-EBITDA is 13.60. Bio-Techne's value of 30.53 is 124.5% above this benchmark. Historically, Bio-Techne's own EV-to-EBITDA has ranged from 20.02 to 89.25 over the past decade. While the company's 10-year median is 32.46 vs. the industry median of 13.60, Bio-Techne has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Biotechnology company?
The median EV-to-EBITDA among Biotechnology companies is 13.60, based on 401 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio-Techne's current EV-to-EBITDA of 30.53 is 124.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bio-Techne. For the Biotechnology industry, the median EV-to-EBITDA is 13.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Techne's current EV-to-EBITDA is 30.53, which is near median its own 10-year median of 32.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current EV-to-EBITDA of 30.53. The stock's GF Value™ is MXN1,071.89, compared to a current price of MXN1,090.00 — trading 1.7% above its estimated fair value. The current EV-to-EBITDA is 30.53, which is near median its 10-year median of 32.46 and 124.5% above the Biotechnology industry median of 13.60. Bio-Techne's overall GF Score™ is 88/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current EV-to-EBITDA is 30.53 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Techne (MEX:TECH) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Techne stock appears to be overvalued.
The current stock price of MXN1,090.00 is trading 1.7% above its estimated GF Value™ of MXN1,071.89.
Key valuation signals for MEX:TECH:
EV-to-EBITDA: 30.53 (near median its 10-year median of 32.46)
GF Value™: MXN1,071.89 vs. price of MXN1,090.00 (1.7% above fair value)
Industry Position: 124.5% above the Biotechnology median (#297 of 401)
No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
88GF Score
Get the complete analysis for MEX:TECH
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TECH has been successfully added to your 
